(Q50746664)

18 March 2018

title

Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer's disease. (English)

1 reference

18 March 2018

0 references

0 references

Sönke Arlt

1

1 reference

18 March 2018

Tomas Müller-Thomsen

series ordinal

2

1 reference

18 March 2018

Ulrike Beisiegel

series ordinal

3

1 reference

18 March 2018

Anatol Kontush

series ordinal

4

1 reference

18 March 2018

publication date

10 August 2012

1 reference

18 March 2018

published in

Neurochemical Research

1 reference

18 March 2018

volume

37

1 reference

18 March 2018

issue

12

1 reference

18 March 2018

page(s)

2706-2714

1 reference

18 March 2018

https://scigraph.springernature.com/pub.10.1007/s11064-012-0860-8

exact match

0 references

cites work

Chemistry and biochemistry of oxidative stress in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Increased lipoprotein oxidation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Antioxidant approaches for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Oxidative stress in diabetes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Why vitamin E therapy fails for treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Vitamin E in neurodegenerative disorders: Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0860-8

Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

12 December 2020

Antioxidant and co-antioxidant activity of vitamin C. The effect of vitamin C, either alone or in the presence of vitamin E or a water-soluble vitamin E analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes

1 reference

12 December 2020

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI

1 reference

12 December 2020

Time-course of oxidation of lipids in human cerebrospinal fluid in vitro

1 reference

12 December 2020

Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease

1 reference

12 December 2020

Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease.

1 reference

12 December 2020

10.1007/S11064-012-0860-8

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018